270 PASSIVE IMMUNIZATION 



Jobling, J. W., and Strouse, S. Immunization with Proteolytic Cleavage 

 Products of Pneumococci, Jour. Exp. Med., 1912, xvi, 860. 



Dochez, A. R. The Presence of Protective Substances in Human Serum dur- 

 ing Lobar Pneumonia, Jour. Exp. Med., 1912, xvi, 665. 



Neufeld, F., and Handel, L. Zur Frage d. Serumtherapie d. Pneumonic und 

 d. Wertbestimmung d. Pneumokokkenserums, Berl. klin. Woch., 1912, p. 680. 



Avery, O. T. The Distribution of the Immune Bodies Occurring in Anti- 

 pneumococcus Serum, Jour. Exp. Med., 1915, xxi, 133. 



Swift, H. F., and Ellis, A. W. M. A Study of the Spirocheticidal Action of 

 the Serum of Patients Treated with Salvarsan, Jour. Exp. Med., 1913, xviii, 435. 



Rytina, A. G., and Judd, C. C. W. The Treatment of Cerebrospinal Syphilis 

 by Intraspinous Injections of Salvarsanized Serum, Amer. Jour. Med. Sci., 

 February, 1915, 247. 



Neisser, E., and Doering, H. Zur Kenntniss d. haemolytischen Eigenschaf- 

 ten d. menschlichen Serums, Berl. klin. Woch., 1901, xxxviii, 539. 



Moss, W. L. Studien ttber Isoagglutinine und Isohaemolysine, Fol. serol, 

 1910, v, 267. 



Moss, W. L. Paroxysmale Haemoglobinurie, Blutstudien in drei Fallen, Fol. 

 serol., 1911, vii, 1117. 



Ottenberg, R. Studies in Isoagglutination : Transfusion and the Question of 

 Intravascular Agglutination, Jour. Exp. Med., 1911, xiii, 425. 



